戻る
Luye Pharma Group Ltd (LYPHF) 収入
主要データ
前終値
$0.3775
始値
$0.395
当日レンジ
$0.3775 - $0.395
52週レンジ
$0.2552 - $0.395
取引高
400
平均取引高
36
配当利回り
--
1株当たり利益(TTM)
0.02
時価総額
$1.5B
LUYE PHARMA GROUP LIMITEDとは何ですか？
Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. The company is headquartered in Yantai, Shandong and currently employs 5,115 full-time employees. The company went IPO on 2014-07-09. The firm operates four segments, including Oncology Drugs segment, Cardiovascular System Drugs segment, Alimentary Tract and Metabolism Drugs segment, and Central Nervous System Drugs segment. The Oncology Drugs segment provides Lipusu, Boyounuo, Baituowei, CMNa and Mimeixin and other drugs. The Cardiovascular System Drugs segment provides Xuezhikang, Oukai and Maitongna and other drugs. The Alimentary Tract and Metabolism Drugs segment provides Bei Xi and other drugs. The Central Nervous System Drugs segment provides Seroquel, Ruoxinlin, Rykindo, Meibirui and Jinyouping and other drugs.